ENTITY Hits Medicine

Hits Medicine

PulseAugur coverage of Hits Medicine — every cluster mentioning Hits Medicine across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

TIMELINE

2026-07-14 partnership Hits Medicine granted AstraZeneca global rights to develop and commercialize Shuwozhe® in a licensing agreement. source

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_141864 · Jul 14 · 04:53

Hits Medicine licenses Shuwozhe® to AstraZeneca for up to $1.9B plus royalties

Hits Medicine has entered into a licensing agreement with AstraZeneca, granting the global rights to develop and commercialize its drug Shuwozhe®. In return, Hits Medicine will receive an upfront payment of $600 million…